查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1533590

次世代定序市场规模、份额和成长分析：按产品/服务、技术、最终用户、地区划分 - 产业预测，2024-2031 年

Next Generation Sequencing Market Size, Share, Growth Analysis, By Product & Service, By Technology, By End User, By Region - Industry Forecast 2024-2031
出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2022年全球次世代定序市场规模将为78.2亿美元，从2023年的92.7亿美元成长到2031年的360.4亿美元，预计到2031年（2024年~2031年）将达到360.4亿美元。成长率为18.5%。

次世代定序(NGS) 是一项先进技术，利用大规模并行性同时对数百万至数十亿条 DNA 链进行定序。 NGS，有时也称为高通量定序，与传统的桑格定序方法相比具有显着的优势。与依赖片段克隆策略的桑格定序不同，NGS具有成本效益高、准确度高、快速出结果的特性。即使使用最小的样品量也可以获得准确的结果。因此，NGS 已成为多个领域的重要工具，包括生物标记发现、癌症研究、个人化医疗、农业和动物测试。基因组定序的应用也扩展到了解 COVID-19 等疾病的传播。英国 COVID-19 基因组联盟 (COG-UK) 成立于 2020 年 3 月，利用全基因组定序来探索冠状病毒基因组。该联盟包括 Wellcome Sanger Institute、NHS、公共卫生机构和多个学术机构之间的合作。这些组织的共同努力旨在绘製病毒的进化和传播模式，并提高我们对干预措施如何影响疾病进展和治疗策略的理解。

目录

介绍

  • 研究目的
  • 定义
  • 市场范围

调查方法

  • 资讯采购
  • 次要/一级资讯来源
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 市场概况展望
  • 供需趋势分析
  • 按细分市场的机会分析

市场动态及展望

  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务
  • 波特的分析

主要市场考察

  • 技术分析
  • 价格分析
  • 价值链分析
  • 市场生态系统
  • Start-Ups分析
  • 专利分析
  • 客户和购买标准分析
  • 监管环境
  • 创新矩阵
  • 重点投资分析
  • 关键成功因素
  • 市场魅力指数
  • 竞争程度

次世代定序市场：依产品/服务分类

  • 市场概况
  • NGS耗材
  • 定序服务
    • EXOME靶向定序和自订面板
    • RNA定序
    • 从头定序
    • 晶片定序
    • 全基因组序列分析
    • 甲基序列
    • 其他定序服务
  • 预测序产品和服务
    • 文库製备/靶向序列捕获
    • 品管
  • NGS平台
    • 照明公司
    • NovaSeq系统
    • 下一代定序系统
    • 米定序系统
    • iSeq 100 系统
    • MiniSeq系统
    • 热渔科学
    • 牛津奈米孔技术
    • 太平洋生物科学公司
    • 其他NGS平台
  • 生物资讯学
    • NGS资料分析服务
    • NGS资料分析软体和工作台
    • NGS储存、管理和云端运算解决方案
  • NGS 平台服务

次世代定序市场：依技术分类

  • 市场概况
  • 合成定序
  • 离子半导体定序
  • 奈米孔定序
  • 单分子即时定序
  • 其他定序技术

次世代定序市场：依应用分类

  • 市场概况
  • 诊断
    • 癌症诊断
    • 感染疾病诊断
    • 生殖健康检查
    • 其他诊断应用
  • 药物发现与开发
    • 药物基因组学
    • 其他药物发现与开发应用
  • 农业和动物研究
  • 其他用途

次世代定序市场：依最终用户划分

  • 市场概况
  • 学术机构/研究中心
  • 製药和生物技术公司
  • 医院/诊所
  • 参考实验室
  • 其他最终用户

次世代定序市场规模：按地区划分

  • 市场概况
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲 (MEA)
    • 海湾合作委员会国家
    • 南非
    • 其他中东/非洲地区

竞争格局

  • 前5名企业对比
  • 主要企业市场定位（2023年）
  • 主要市场参与者所采取的策略
  • 近期市集活动
  • 主要企业市场占有率（2023年）

主要企业简介

  • Illumina Inc.（US）
  • Thermo Fisher Scientific Inc.（US）
  • PerkinElmer Inc.（US）
  • BGI Group（China）
  • Agilent Technologies Inc.（US）
  • Eurofins Scientific SE（Luxembourg）
  • Pacific Biosciences of California Inc.（US）
  • Oxford Nanopore Technologies（UK）
  • QIAGEN NV（Netherlands）
  • F. Hoffmann-La Roche AG（Switzerland）
  • GENEWIZ Inc.（US）
  • Psomagen, Inc.（South Korea）
  • 10x Genomics Inc.（US）
  • Takara Bio（Japan）
  • Zymo Research（US）
  • NuGen Technologies（US）
  • Hamilton Company（US）
  • Beckman Coulter（US）
  • Becton, Dickinson, and Company（US）
  • Lucigen Corporation（US）
  • Novogene Co., Ltd.（China）
简介目录
Product Code: SQMIG35D2046

Global Next Generation Sequencing Market size was valued at USD 7.82 billion in 2022 and is poised to grow from USD 9.27 billion in 2023 to USD 36.04 billion by 2031, growing at a CAGR of 18.5% in the forecast period (2024-2031).

Next-generation sequencing (NGS) is an advanced technique that utilizes massive parallelism to sequence millions or even billions of DNA strands simultaneously. Often referred to as high-throughput sequencing, NGS offers significant advantages over traditional Sanger sequencing methods. Unlike Sanger sequencing, which relies on fragment-cloning strategies, NGS is characterized by its cost-effectiveness, high accuracy, and rapid results. It is capable of delivering precise outcomes even with minimal sample quantities. As a result, NGS has become a critical tool in various fields, including biomarker discovery, cancer research, personalized medicine, agriculture, and animal studies. The application of genome sequencing extends to understanding the spread of diseases such as COVID-19. The COVID-19 Genomics U.K. Consortium (COG-U.K.), established in March 2020, utilizes whole-genome sequencing to explore the coronavirus genome. This consortium includes collaborations between the Wellcome Sanger Institute, the NHS, public health agencies, and several academic institutions. The collective efforts of these organizations aim to map the virus's evolution and transmission patterns, enhancing our understanding of how interventions impact disease progression and treatment strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Next Generation Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Next Generation Sequencing Market Segmental Analysis

The next generation sequencing market is segmented into Product and Service, Technology, Application, End User and region. Based on the Product & Service, the market is segmented into NGS Consumables, Sequencing Services (Exome & Targeted Resequencing and Custom Panels, RNA Sequencing, DE NOVO Sequencing, Chip Sequencing, Whole-genome sequencing, MethYl Sequencing, Other Sequencing Services), Pre-sequencing Products & Services (Library Preparation And Target Enrichment, Quality Control), NGS Platforms (Illumina [NovaSeq Systems, Nextseq Systems, Miseq Systems, iSeq 100 Systems, Miniseq Systems], Thermo Fisher Scientific, Oxford Nanopore Technologies, Pacific Biosciences, Other NGS Platforms), Bioinformatics (NGS Data Analysis Services, NGS Data Analysis Software and Workbenches, NGS Storage, Management, And Cloud Computing Solutions), Services for NGS Platforms. Based on the Technology, the market is segmented into Sequencing by Synthesis, Ion Semiconductor Sequencing, Nanopore Sequencing, Single-molecule Real-time Sequencing, and Other Sequencing Technologies. Based on Application, the market is segmented into Diagnostics (Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Other Diagnostic Applications, Drug Discovery and Development (Pharmacogenomics, Other Drug Discovery and Development Applications), Agricultural and Animal Research, Other Applications. Based on the End-user, the market is segmented into Academic Institutes and Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, Reference Laboratories, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia-Pacific, South America, and Middle East and Africa.

Drivers of the Global Next Generation Sequencing Market

The development of new and innovative technologies has led to the rise of next-generation sequencing (NGS), which is characterized by its speed, portability, and user-friendliness. These advancements enable quicker and more precise analyses, with significantly reduced turnaround times. By leveraging these technological improvements, companies gain a competitive edge, leading to increased investments in research and development. This, in turn, drives market growth and enhances the overall investment in innovation. The introduction of NGS represents a major leap forward in sequencing technology, offering substantial benefits in terms of efficiency and accuracy. These enhancements facilitate more rapid and reliable data analysis, positioning firms at the forefront of the industry. As businesses capitalize on these advancements, they contribute to a surge in market activity and foster further innovation, reinforcing their market position and driving continued growth in the sector.

Restraints in the Global Next Generation Sequencing Market

Next-generation sequencing generates enormous volumes of data, leading to significant challenges related to data storage, management, and analysis. The sheer scale of data produced necessitates the use of advanced and specialized bioinformatics tools and expertise, which may not always be readily available within an organization. These requirements can affect research and development timelines, elevate operational costs throughout the development cycle, and potentially restrict market opportunities. As a result, organizations may face difficulties in efficiently handling and leveraging the vast amounts of data generated by NGS technologies.

Market Trends of the Global Next Generation Sequencing Market

Next-generation sequencing (NGS) is increasingly utilized in both high and low-throughput research due to its growing simplicity, decreasing costs, and enhanced bioinformatics support. The application of NGS-based testing systems is broadening across various clinical fields, including oncology, reproductive health, and genetics. Organizations and companies are continuously striving for improvements and advancements in NGS technologies. For instance, RNA-sequencing is evolving to address a wider array of scientific and clinical domains, reflecting the ongoing efforts to expand the capabilities and applications of NGS.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • Start-up Analysis
  • Patent Analysis
  • Customer & Buying Criteria Analysis
  • Regulatory Landscape
  • Innovation Matrix
  • Top Investment Analysis
  • Key Success Factor
  • Market Attractive Index
  • Degree of Competition

Next Generation Sequencing Market by Product & Service

  • Market Overview
  • NGS Consumables
  • Sequencing Services
    • Exome & Targeted Resequencing and Custom Panels
    • RNA Sequencing
    • DE NOVO Sequencing
    • Chip sequencing
    • Whole-genome sequencing
    • Methyl sequencing
    • Other sequencing services
  • Pre-Sequencing Products & Services
    • Library preparation and target enrichment
    • Quality control
  • NGS Platforms
    • Illumina
    • NovaSeq systems
    • NextSeq systems
    • MiSeq systems
    • iSeq 100 systems
    • MiniSeq systems
    • Thermo Fisher Scientific
    • Oxford Nanopore Technologies
    • Pacific Biosciences
    • Other NGS Platforms
  • Bioinformatics
    • NGS Data Analysis Services
    • NGS Data Analysis Software and Workbenches
    • NGS Storage, Management, And Cloud Computing Solutions
  • Services for NGS Platforms

Next Generation Sequencing Market by Technology

  • Market Overview
  • Sequencing by synthesis
  • Ion semiconductor sequencing
  • Nanopore sequencing
  • Single-molecule real-time sequencing
  • Other sequencing technologies

Next Generation Sequencing Market by Application

  • Market Overview
  • Diagnostics
    • Cancer diagnostics
    • Infectious disease diagnostics
    • Reproductive health diagnostics
    • Other diagnostic applications
  • Drug discovery and development
    • Pharmacogenomics
    • Other drug discovery and development applications
  • Agricultural and animal research
  • Other applications

Next Generation Sequencing Market by End user

  • Market Overview
  • Academic institutes and research centers
  • Pharmaceutical and biotechnology companies
  • Hospitals and clinics
  • Reference laboratories
  • Other end users

Next Generation Sequencing Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Illumina Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BGI Group (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific SE (Luxembourg)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pacific Biosciences of California Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oxford Nanopore Technologies (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QIAGEN NV (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GENEWIZ Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Psomagen, Inc. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 10x Genomics Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takara Bio (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zymo Research (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NuGen Technologies (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hamilton Company (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Beckman Coulter (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson, and Company (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lucigen Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novogene Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments